Pure Global
NCT06401915

Intelligent Assistive Technologies for Dementia

National Cheng-Kung University Hospital·ClinicalTrials.govCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Healthy Adult
Study type
Observational
Sponsor & location
Primary sponsor
National Cheng-Kung University Hospital
Location
Tainan, Taiwan
Timeline & enrollment
Phase
N/A
Start date
May 10, 2023
End date
Nov 06, 2023
Enrollment
18 participants
Primary outcome

EQ-5D-5L,Zarit Burden Interview,The General Anxiety Disorder 7(GAD-7),System Usability Scale

Summary

With the HAAL(HeAlthy Ageing eco system for peopLe with dementia) project, the Netherlands,
 Taiwan, Italy, Austria, and Denmark combine their strength, co-create, evaluate and share
 their experiences in supporting dementia care by state-of-the-art AAL bundles.Co-design
 sessions will take place before developing the dashboard, consisting of (in)formal carers,
 and older people/clients they care for. The HAAL project will conduct field trials with the
 first version of the dashboard (Alpha testing) and after Alpha testing, a Beta version of the
 dashboard will be developed according users' feedback. Then more end-users will be
 incorporated in Beta testing.The aims of the dashboard are to provide support to reduce the
 workload of the caregivers and allow psychological relief, which eventually support clients'
 wellbeing.

ICD-10 classifications
Healthy person accompanying sick personObesity, unspecifiedLifestyle-related conditionAdult-onset Still diseaseObesity
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06401915
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06401915 through Pure Global AI's free database. This phase not specified trial is sponsored by National Cheng-Kung University Hospital and is currently Completed. The study focuses on Healthy Adult. Target enrollment is 18 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.